Public health topics for NICE guidance announced
Other topics referred
Technology appraisals
· Gemcitabine for breast cancer
· Docetaxel and paclitaxel for early breast cancer
· Erlotinib and pemetrexed for non-small cell lung cancer
· Ezetimibe for hypercholesterolaemia
Clinical guidelines
· Management of eczema in children
· Management of meningococcal disease and meningitis in children
and adolescents |
The first public
health topics for evaluation by the National Institute for Health and Clinical Excellence have been announced. These, along
with additional topics including a clinical guideline on medicines
concordance, were referred to NICE by the Secretary of State for Health
last week. Interventions that will be assessed include:
· Interventions to reduce transmission of chlamydia and other sexually
transmitted infections, and to reduce the rate of pregnancy in under
18-year-olds
· Brief interventions and referral for smoking cessation in primary care,
including pharmacy, dental and GP services, with particular reference
to pregnant smokers and other disadvantaged groups
NICE will also produce guidance on public health programmes, including:
· Guidance for pharmacies, primary care, local authorities and workplaces
on the optimal provision of smoking cessation services, including provision
of nicotine replacement therapy
· Guidance for pharmacists, midwives, health visitors and other providers
of primary care services on improving the nutrition of pregnant and breastfeeding
mothers, and children, in low income households
Proposals for how NICE will develop public health guidance are currently
out for consultation
with practitioners and the public (PJ, 26 March,
p353).
Medicines Partnership has been working with NICE for several months with
the aim of getting medicines concordance included on its work programme.
Joanne Shaw, director of Medicines Partnership, told The Journal that
the guidance will be an important way of reaching a large number of health
professionals and informing and educating them about the importance of
partnership and how to achieve it.
“It is a powerful communication mechanism, a way of underscoring the importance
of [concordance] in the eyes of the NHS,” she said.
“We would expect the guideline to draw upon all of the evidence that shows
the
benefit of concordance and indicates how health professionals can interact
successfully with patients to create partnerships,” she added. |